KOELIS was founded with the vision to offer the most confident and accurate prostate cancer diagnosis to their patients, avoiding any under or overtreatment and preserving quality of life.

With the support of forward-thinking partners, investors, and hospitals, our vision is rapidly becoming a reality.

Today, the KOELIS Trinity® platform is recognized as a gold standard for MRI fusion Prostate biopsy, providing accuracy and reliability at every step of the process, from biopsy and active surveillance to treatment and follow-up.

Over 300 hospitals in more than 25 countries have already given 300,000 men access to more precise prostate cancer diagnosis thanks to our technologies.

Koelis n'a pas encore publié dans son catalogue.